Pneumococcal polysaccharide vaccine —known as Pneumovax 23 —is the first pneumococcal vaccine derived from a capsular polysaccharide, and an important landmark in medical history.

What does pneumococcal polysaccharide vaccine prevent?

Pneumococcal polysaccharide vaccine (PPSV23) can prevent pneumococcal disease. Pneumococcal disease refers to any illness caused by pneumococcal bacteria. These bacteria can cause many types of illnesses, including pneumonia, which is an infection of the lungs.

Who needs pneumococcal polysaccharide vaccine?

CDC recommends routine pneumococcal polysaccharide vaccination for: All adults 65 years or older. People 2 through 64 years old with certain medical conditions. Adults 19 through 64 years old who smoke cigarettes.